← Leaderboards
Charles P France
University Of Texas Hlth Science Center
$39,306,016
Attributed
$40,084,885
Total exposure
18
Grants
16
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $6M · FY2005–25$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$40,084,885 · 18
By mechanism
R01$15,351,730 · 5
U01$10,154,353 · 3
T32$4,822,330 · 1
UH3$4,373,045 · 1
UG3$2,898,106 · 1
K05$1,215,000 · 1
Top collaborators
- Gregory Thomas Collins4 shared
- David Richard Maguire1 shared
Most similar at University Of Texas Hlth Science Center
Same institution · by research overlap
- Shawn Michael Flynn$75,296
Others in their field
Top investigators on “Pharmaceutical Preparations”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David Heimbrook · Leidos Biomedical Research, Inc.$266,816,120
- Leonard Freedman · Leidos Biomedical Research, Inc.$240,520,687
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$196,976,947
- Lawrence Corey · Fred Hutchinson Cancer Center$196,976,947
Research focus
Pharmaceutical PreparationsBehaviorAgonistDoseOpioidDrug AbuseMacaca MulattaProceduresGrantMonkeysBehavioralNeurobiologySelf AdministrationLaboratoriesOpioid ReceptorMorphineWithdrawalDrug AddictionAcuteFentanylNonhuman PrimateDependenceFoodStimulus
Grant awards (112)
Development of the novel mu-opioid receptor antagonist methocinnamox (MCAM) for preventing relapse and overdose$3,937,344
U01 · FY2025 · DA · contact PI
Discriminative Stimulus Effects of Opioid Withdrawal$642,365
R01 · FY2025 · DA · contact PI
Postdoctoral Training in Drug Abuse Research: Behavior & Neurobiology$498,195
T32 · FY2025 · DA · contact PI
Behavior, Biology, and Chemistry: Translational Research in Substance Use Disorders$1
R13 · FY2025 · DA · contact PI
Development of the novel mu-opioid receptor antagonist methocinnamox (MCAM) for preventing relapse and overdose$3,937,322
U01 · FY2024 · DA · contact PI
Discriminative Stimulus Effects of Opioid Withdrawal$642,365
R01 · FY2024 · DA · contact PI
Postdoctoral Training in Drug Abuse Research: Behavior & Neurobiology$182,963
T32 · FY2024 · DA · contact PI
Behavior, Biology, and Chemistry: Translational Research in Addiction$27,500
R13 · FY2024 · DA · contact PI
Methocinnamox (MCAM): A novel ÃÂõ-opioid receptor antagonist for opioid use disorders$4,218,078
UH3 · FY2023 · DA · contact PI
Discriminative Stimulus Effects of Opioid Withdrawal$642,365
R01 · FY2023 · DA · contact PI
A novel opioid receptor antagonist for treating abuse and overdose$492,438
R01 · FY2023 · DA · contact PI
Postdoctoral Training in Drug Abuse Research: Behavior & Neurobiology$486,018
T32 · FY2023 · DA · contact PI
Methocinnamox (MCAM): A novel opioid receptor antagonist$154,967
UH3 · FY2023 · DA · contact PI
Behavior, Biology, and Chemistry: Translational Research in Addiction$27,500
R13 · FY2023 · DA · contact PI
Discriminative Stimulus Effects of Opioid Withdrawal$514,279
R01 · FY2022 · DA · contact PI
A novel opioid receptor antagonist for treating abuse and overdose$492,438
R01 · FY2022 · DA · contact PI
Postdoctoral Training in Drug Abuse Research: Behavior & Neurobiology$463,325
T32 · FY2022 · DA · contact PI
Methocinnamox (MCAM): A novel Ãõ-opioid receptor antagonist for opioid use disorders$147,995
UG3 · FY2022 · DA · contact PI
Behavior, Biology, and Chemistry: Translational Research in Addiction$27,500
R13 · FY2022 · DA · contact PI
Discriminative Stimulus Effects of Opioid Withdrawal$656,399
R01 · FY2021 · DA · contact PI
A novel opioid receptor antagonist for treating abuse and overdose$492,438
R01 · FY2021 · DA · contact PI
Repurposing drugs in mixtures to treat drug abuse$361,736
U01 · FY2021 · DA · contact PI
Postdoctoral Training in Drug Abuse Research: Behavior & Neurobiology$234,147
T32 · FY2021 · DA · contact PI
Behavior, Biology, and Chemistry: Translational Research in Addiction$27,500
R13 · FY2021 · DA · contact PI
A novel opioid receptor antagonist for treating abuse and overdose$492,438
R01 · FY2020 · DA · contact PI
Training in drug abuse research: behavior and neurobiology$420,746
T32 · FY2020 · DA · contact PI
Repurposing drugs in mixtures to treat drug abuse$361,736
U01 · FY2020 · DA · contact PI
Behavior, Biology, and Chemistry: Translational Research in Addiction$27,500
R13 · FY2020 · DA · contact PI
Methocinnamox (MCAM): A novel ÃÂõ-opioid receptor antagonist for opioid use disorders$2,750,111
UG3 · FY2019 · DA · contact PI
A novel opioid receptor antagonist for treating abuse and overdose$616,485
R01 · FY2019 · DA · contact PI
Training in drug abuse research: behavior and neurobiology$409,717
T32 · FY2019 · DA · contact PI
Repurposing drugs in mixtures to treat drug abuse$409,094
U01 · FY2019 · DA · contact PI
Discriminative Stimulative effects of Opioid Withdrawal$366,000
R01 · FY2019 · DA · contact PI
Behavior, Biology, and Chemistry: Translational Research in Addiction$25,000
R13 · FY2019 · DA · contact PI
Repurposing drugs in mixtures to treat drug abuse$425,172
U01 · FY2018 · DA · contact PI
Training in drug abuse research: behavior and neurobiology$383,616
T32 · FY2018 · DA · contact PI
Discriminative Stimulative effects of Opioid Withdrawal$366,000
R01 · FY2018 · DA · contact PI
Discriminative stimulus effects of opioid withdrawal$182,527
R01 · FY2018 · DA · contact PI
Behavior, Biology, and Chemistry: Translational Research in Addiction$25,000
R13 · FY2018 · DA · contact PI
Training in drug abuse research: behavior and neurobiology$369,269
T32 · FY2017 · DA · contact PI
Discriminative Stimulative effects of Opioid Withdrawal$366,000
R01 · FY2017 · DA · contact PI
Discriminative stimulus effects of opioid withdrawal$151,738
R01 · FY2017 · DA · contact PI
Behavior, Biology, and Chemistry: Translational Research in Addiction$25,000
R13 · FY2017 · DA · contact PI
Training in drug abuse research: behavior and neurobiology$1
T32 · FY2017 · DA · contact PI
Discriminative Stimulative effects of Opioid Withdrawal$362,340
R01 · FY2016 · DA · contact PI
Training in drug abuse research: behavior and neurobiology$351,981
T32 · FY2016 · DA · contact PI
Behavior, Biology, and Chemistry: Translational Research in Addiction$25,000
R13 · FY2016 · DA · contact PI
Discriminative Stimulative effects of Opioid Withdrawal$362,400
R01 · FY2015 · DA · contact PI
Training in Drug Abuse Research: Behavior and Neurobiology$288,928
T32 · FY2015 · DA · contact PI
Evaluation of the 5-HT2C agonist lorcaserin as potential treatment for cocaine ab$147,453
U01 · FY2015 · DA · contact PI
Behavior, Biology, and Chemistry: Translational Research in Addiction$25,000
R13 · FY2015 · DA · contact PI
Discriminative Stimulus Effects of Opioid Withdrawal$324,101
R01 · FY2014 · DA · contact PI
Delay discounting: effects of drug dependence and withdrawal$271,903
R01 · FY2014 · DA · contact PI
Training in Drug Abuse Research: Behavior and Neurobiology$214,123
T32 · FY2014 · DA · contact PI
Evaluation of the 5-HT2C agonist lorcaserin as potential treatment for cocaine ab$168,935
U01 · FY2014 · DA · contact PI
Behavioral Pharmacology of Drug Dependence$126,360
K05 · FY2014 · DA · contact PI
Training in Drug Abuse Research: Behavior and Neurobiology$59,502
T32 · FY2014 · DA · contact PI
Behavior, Biology, and Chemistry: Translational Research in Addiction$25,000
R13 · FY2014 · DA · contact PI
Evaluation of the 5-HT2C agonist lorcaserin as potential treatment for cocaine ab$405,561
U01 · FY2013 · DA · contact PI
Discriminative Stimulus Effects of Opioid Withdrawal$311,137
R01 · FY2013 · DA · contact PI
Delay discounting: effects of drug dependence and withdrawal$261,027
R01 · FY2013 · DA · contact PI
Training in Drug Abuse Research: Behavior and Neurobiology$202,507
T32 · FY2013 · DA · contact PI
Behavioral Pharmacology of Drug Dependence$126,360
K05 · FY2013 · DA · contact PI
Behavior, Biology, and Chemistry: Translational Research in Addiction$25,000
R13 · FY2013 · DA · contact PI
Discriminative Stimulus Effects of Opioid Withdrawal$324,101
R01 · FY2012 · DA · contact PI
Delay discounting: effects of drug dependence and withdrawal$271,600
R01 · FY2012 · DA · contact PI
Training in Drug Abuse Research: Behavior and Neurobiology$157,185
T32 · FY2012 · DA · contact PI
Behavioral Pharmacology of Drug Dependence$126,360
K05 · FY2012 · DA · contact PI
Behavior, Biology, and Chemistry: Translational Research in Addiction$25,000
R13 · FY2012 · DA · contact PI
Discriminative Stimulus Effects of Opioid Withdrawal$324,101
R01 · FY2011 · DA · contact PI
Delay discounting: effects of drug dependence and withdrawal$270,084
R01 · FY2011 · DA · contact PI
Behavioral Pharmacology of Drug Dependence$126,360
K05 · FY2011 · DA · contact PI
Training in Drug Abuse Research: Behavior and Neurobiology$100,107
T32 · FY2011 · DA · contact PI
Behavior, Biology, and Chemistry: Translational Research in Addiction$25,000
R13 · FY2011 · DA · contact PI
Discriminative Stimulus Effects of Opioid Withdrawal$334,125
R01 · FY2010 · DA · contact PI
Delay discounting: effects of drug dependence and withdrawal$278,438
R01 · FY2010 · DA · contact PI
Behavioral Pharmacology of Drug Dependence$126,360
K05 · FY2010 · DA · contact PI
Delay discounting and fMRI in rhesus monkeys$185,417
R21 · FY2009 · DA · contact PI
Behavioral Pharmacology of Drug Dependence$116,640
K05 · FY2009 · DA · contact PI
Behavior, Biology, and Chemistry: Translational Research in Addiction$25,000
R13 · FY2009 · DA · contact PI
Delay discounting and fMRI in rhesus monkeys$222,000
R21 · FY2008 · DA · contact PI
Behavioral Pharmacology of Drug Dependence$116,640
K05 · FY2008 · DA · contact PI
Discriminative stimulus effects of opioid withdrawal$276,869
R01 · FY2007 · DA · contact PI
Behavioral Pharmacology of Drug Dependence$116,640
K05 · FY2007 · DA · contact PI
Discriminative effects of benzodiazepine withdrawal$285,138
R01 · FY2006 · DA · contact PI
Discriminative stimulus effects of opioid withdrawal$285,138
R01 · FY2006 · DA · contact PI
Behavioral Pharmacology of Drug Dependence$116,640
K05 · FY2006 · DA · contact PI
DISCRIMINATIVE EFFECTS OF BENZODIAZEPINE WITHDRAWAL$11,603
P51 · FY2006 · RR · contact PI
DISCRIMINATIVE STIMULUS EFFECTS OF OPIOID WITHDRAWAL$11,603
P51 · FY2006 · RR · contact PI
Discriminative stimulus effects of opioid withdrawal$292,000
R01 · FY2005 · DA
Discriminative effects of benzodiazepine withdrawal$292,000
R01 · FY2005 · DA
Behavioral Pharmacology of Drug Dependence$116,640
K05 · FY2005 · DA
Discriminative stimulus effects of opioid withdrawal$292,000
R01 · FY2004 · DA
Discriminative effects of benzodiazepine withdrawal$292,000
R01 · FY2004 · DA
GHB abuse: chemistry and neurobiology$330,966
R01 · FY2003 · DA
Discriminative stimulus effects of opioid withdrawal$292,000
R01 · FY2003 · DA
Discriminative effects of benzodiazepine withdrawal$219,000
R01 · FY2003 · DA
BEHAVIORAL PHARMACOLOGY OF OPIOIDS$122,472
K02 · FY2003 · DA
GHB abuse: chemistry and neurobiology$331,848
R01 · FY2002 · DA
Discriminative effects of benzodiazepine withdrawal$217,938
R01 · FY2002 · DA
DISCRIMINATIVE STIMULUS EFFECTS OF OPIOID WITHDRAWAL$177,736
R01 · FY2002 · DA
BEHAVIORAL PHARMACOLOGY OF OPIOIDS$122,472
K02 · FY2002 · DA
GHB abuse--chemistry and neurobiology$343,829
R01 · FY2001 · DA
DISCRIMINATIVE STIMULUS EFFECTS OF OPIOID WITHDRAWAL$182,740
R01 · FY2001 · DA
DISCRIMINATIVE EFFECTS OF BENZODIAZEPINE WITHDRAWAL$134,232
R01 · FY2001 · DA
BEHAVIORAL PHARMACOLOGY OF OPIOIDS$111,986
K02 · FY2001 · DA
DISCRIMINATIVE STIMULUS EFFECTS OF OPIOID WITHDRAWAL$118,148
R01 · FY2000 · DA
DISCRIMINATIVE EFFECTS OF BENZODIAZEPINE WITHDRAWAL$91,611
R01 · FY2000 · DA
BEHAVIORAL PHARMACOLOGY OF OPIOIDS$58,006
K02 · FY2000 · DA
DISCRIMINATIVE STIMULUS EFFECTS OF OPIOID WITHDRAWAL$53,696
R01 · FY2000 · DA
BEHAVIORAL PHARMACOLOGY OF OPIOIDS$37,261
K02 · FY2000 · DA
DISCRIMINATIVE EFFECTS OF BENZODIAZEPINE WITHDRAWAL$31,209
R01 · FY2000 · DA